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Summary There is clear clinical evidence that tumours in anaemic patients are difficult to control with
radiotherapy. We have studied the radiosensitivity of two transplantable mouse tumours, the SCCVII/St
carcinoma and the KHT sarcoma in hosts made anaemic either with an iron poor diet or as a result of tumour
growth. The haemoglobin level and haematocrits of mice on the low iron diet fell to about 60% of normal
within 11 weeks. The number of clonogenic cells after a single X-ray dose of 20Gy was slightly lower
(P<0.05) in the anaemic animals (2.3 x I04g-') than in controls (5.2 x I04g-') though there was no
significant difference in the surviving fractions. Mice bearing KHT tumours became anaemic with haematocrits
falling to 65% of normal as their tumours grew from 300-1200 mg. A second 'test' tumour was implanted one
week after the first 'anaemia-inducing' tumour so that estimates of radiosensitivity could all be carried out on
tumours within the same size range (150-300mg). Radiosensitivity was significantly greater in the most
anaemic hosts with 2.2 x I04 cells g-' surviving a dose of 20 Gy compared with 6.7 x 04g-' in controls
(P<0.01). These results are consistent with most published data for mouse tumours though not for many
human tumours.
A major area of interest in cancer research in recent years
has been the development of assays which predict the poten-
tial outcome of a variety of therapies in the individual cancer
patient. The effective application of this approach appears
possible as early clinical trials have indicated, but until these
sophisticated techniques are fully developed the clinician
must rely on better established prognostic indicators such as
grade and stage of disease. There is now also considerable
evidence that for tumours in some sites haemoglobin levels
have a major impact on the outcome of radiotherapy (Bush,
1986; Dische, 1990; Hirst, 1986; Overgaard et al., 1989)
though not every study supports this view (Fazekas et al.,
1989). The influence of haemoglobin level, a conceptually
simple parameter, on tumour radiosensitivity, has proved to
be particularly difficult to model in animal systems and as yet
no satisfactory explanation has been offered to explain the
conflicting findings. Because we do not fully understand why
anaemia arises in some cancer patients it is difficult to
develop a truly representative small-animal model of the
human condition. At least four different techniques have
been employed in mice, including exchange blood transfusion
(Hirst & Wood, 1987) administration of phenylhydrazine
(Hewitt & Blake, 1971; Siemann et al., 1989; Tanaka et al.,
1969) low iron diets (McCormack et al., 1990; Walker et al.,
in press) the effects of growth of some tumours (Hill et al.,
1971) and kidney irradiation (Rojas et al., 1987). The results
of these studies will be considered later, but it is at once
obvious that several inconsistencies exist and that the induc-
tion of anaemia probably brings into effect adaptive
mechanisms that have a profound influence on tumour
radiosensitivity.
A common feature of the anaemia of cancer is that it
occurs relatively gradually (with the exception of the occas-
ional episode of bleeding from some tumours), theoretically
permitting physiological adaptation to the reduction in oxy-
gen carrying capacity of the blood. In the present study we
evaluated two distinctly different methods of inducing chron-
ic anaemia in the mouse, the use of an iron deficient diet and
the growth of KHT sarcomas which have been shown to
induce anaemia in their hosts (Hill et al., 1971). Our results
are broadly consistent with the view that physiological adap-
tation is an important factor in determining radiobiological
hypoxic fraction and reinforce the view that some aspects of
the human disease are not adequately modelled in these
tumour systems.
Materials and methods
Mice and tumour systems
Female C3H/Km mice, 12-14 weeks old and about 27 g in
weight were used. Different procedures were employed for
the two tumour systems, the SCCVII/St carcinoma (Hirst et
al., 1982) and the KHT sarcoma (Kallman et al., 1967). Both
tumours were implanted intradermally as a cell suspension
(2 x 105 cells in 0.05 ml of medium) and allowed to grow to
the treatment size for irradiation of 150-300 mg. The
SCCVII/St tumours were implanted when the mice had been
on the low iron diet for 8 weeks. A different procedure was
used in the case of the KHT tumour transplants in most
experiments: one week after the first tumour implant on the
left dorsum a second implant was made on the opposite side
so that by the time the second tumour had reached the
treatment size of 150-300 mg the first tumour had reached a
larger size 1000-1500mg and had induced anaemia in the
host.
Irradiation and assay treatment
The tumour-bearing mice were irradiated whole body with a
250 kVp X-ray machine at a dose rate of 2.85 Gy min-'. The
mice were killed by neck fracture 24 h later. Their tumours
were excised, weighed and disaggregated using mechanical
chopping and digestion for 30 min in an enzyme cocktail of
pronase, collagenase and DNAase (Hirst et al., 1982). The
density of cells in the resulting suspension was counted in a
haemacytometer and the cells plated in Waymouth's medium
in Petri dishes according to the expected level of cell surival.
Three replicate plates in each of two separate dilutions were
prepared from each tumour sample. Dishes were placed in an
incubator with a humidified atmosphere of 5% CO2 in air at
37°C for 12-14 days, by which time surviving tumour cells
had formed discrete colonies. The number of colonies with
more than 50 cells was counted in each dish. Final surviving
fractions were calculated by dividing the fraction of cells
surviving in the treated groups by the plating efficiency of
untreated controls. The number of clonogenic cells g-' of
tumour was calculated by taking the cell yield from each
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tumour and multiplying by the fraction of cells surviving in
that group.
Low iron diet
From weaning at 22 days the mice in some experiments were
fed a diet containing less than 12 ppm of iron. The normal
stainless steel wire cage tops were replaced with perspex
items. Water bottles were filled with distilled water and the
rubber and steel stoppers exchanged for cork and glass
replacements. Sawdust bedding was also tested for iron con-
tent which was found to be less than 12 ppm.
Measurement ofhaematocrit andhaemoglobin content
A small (10 i1) blood sample was taken from the tails of the
mice into a capillary tube which was sealed and spun to
determine the relative packed cell volume. This microhaem-
atocrit method, adapted for very small volumes was found to
give reliable replicate readings (± 2%) of the same sample.
In one series of experiments a similar blood sample was
tested for haemoglobin content using a proprietary kit (Sig-
ma Chemical Company).
Results
The effect of the low iron diet on the haematocrit and
haemoglobin levels of the mice was not always consistent. It
was essential that all sources of iron were eliminated from
the cage and even then some animals failed to become
anaemic. In general, all the animals fed the low iron diet
within a particular experiment showed some drop in haemat-
ocrit while in another experiment few of the animals became
anaemic. While the removal of all sources of iron from the
cage environment increased the probabilty of achieving anae-
mia, we were unable to obtain the effects consistently. Other
authors have reported similar difficulties (McCormack et al.,
1990), which they attributed to the particular diet used.
However, since the purpose of our study was to determine
the effect of anaemia on tumour growth and radiosensitivity,
data will be shown for those experiments in which anaemia
was successfully achieved. Figure la,b shows haematocrit and
haemoglobin levels after different times on the low iron diet.
Both parameters fell progressively for 11 weeks at which time
the tumours were irradiated.
The growth rate of tumours in the mice on the low iron
diet was significantly slower than that in control animals as
shown in Figure 2. To compensate for this effect tumours
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Figure 2 Growth of the SCCVII/St carcinoma in mice on low
iron (0) or normal (0) diets. Tumours were implanted after the
mice had been on the diet for 8 weeks. Error bars represent
± 1 s.e.m.
were implanted 4 days later in the control animals to permit
radiation treatment at approximately the same size on the
same day. Contrary to expectations, however, the mice on
the diet gained body weight faster than the controls (data not
shown). This result is the opposite of that obtained by
McCormack et al. (1990) with a low iron diet. The radiosen-
sitivity of the SCCVII/St tumours in relation to the haemato-
crit of the host animal is shown in Figure 3a. A threshold
haematocrit of 30% was taken, which in our animals was
equivalent to a haemoglobin content of 9.4 g%. The number
of clonogenic cells surviving a single dose of 20 Gy was lower
by a factor of 2.4 in the group with the lower haematocrits, a
difference that was statistically significant (P<0.05). There
was, however, no significant difference between the surviving
fractions obtained in the two groups. This discrepancy can be
explained entirely by a 3.7 fold lower cell yield from the
SCCVII/St tumours in the chronically anaemic group.
Induction of anaemia was also achieved in KHT tumour-
bearing mice as first described by Hill et al. (1971). The fall
in haematocrit with tumour growth is illustrated in Figure 4.
Haematocrits fell rapidly (over 6-8 days) while tumours
grew from 300-1000 mg though, surprisingly, no further
reduction occurred as size increased further to 2000mg. It
was therefore considered sufficient to allow the tumours to
grow to about 1200 mg to produce anaemia. The radiosen-
sitivity of a second tumour implanted either one week after
the first on the opposite flank (i.e. in an anaemic host at the
time of irradiation) or implanted at the same time as the one
on the opposite flank (normal haematocrit at the time of
b
-30 >30 25-30 31-35 36-40 41-45 46-50
* P< 0.05 Haematrocrit range
* *P< 0.01
Weeks on diet
Figure 1 The effect of low iron (0) and normal (0) diets on the
haemoglobin content (a) and haematocrit (b) of blood in 101l
samples from the tail. Error bars represent ± s.e.m.
Figure 3 (a) The number of clonogenic cells g-' of tumour
surviving a single X-ray dose of 20 Gy in mice with haematocrits
< 30% or >30%. (b) The number of clonogenic cellsg-' of
tumour surviving after a single X-ray dose of 20 Gy in mice with
a range of haematocrits. The number of animals in each group is
shown within each hatched bar. Errors are ± 1 s.e.m.ANAEMIA AND TUMOUR RADIOSENSITIVITY 501
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is shown in Figure
3b. The number of clonogenic
cells g-' surviving
a single
dose of 20 Gy was significantly
lower (P<0.01)
in mice with lower haematocrits though the
effect was really quite small, a factor of three when compar-
ing
mice with haematocrits between 25 and 30% (the lowest
survival)
and those with haematocrits between 46 and
50% (the highest
cell survival). The differences in surviving
fraction between the groups mirrored the clonogenic cell data
the cell yields were not significantly different.
Discussion
The interpretation of the results of this study is rather
difficult because while there were fewer surviving cells in the
tumours from anaemic hosts, only in the case of the tumour-
induced anaemia (KHT study) was this matched by a lower
surviving fraction. We observed only in the low iron diet
study, where anaemia developed very slowly over several
weeks, that the number of viable cells per gram of tumour
was significantly lower than in tumours from hosts with
normal haematocrits.
Why
should the cell yield per gram in SCCVII/St tumours
from anaemic hosts be lower (by a factor of 3.7) than that of
tumours from mice that were not on the low iron diet and
why
was this effect not seen in KHT tumours from mice
made anaemic by tumour growth? A lower cell yield indicates
either a higher proportion of non-cellular mass (e.g. necrosis)
increased susceptibility of the cells from anaemic hosts
rigours
of enzymic disaggregation. A further series of
experiments would be required to test these alternatives in
tumour lines. For the purpose of this discussion, how-
ever,
it would be prudent to emphasise only that our data do
show a significant change in radiosensitivity in the
SCCVII/St tumour after diet-induced anaemia.
What do other studies reveal? There have been relatively
studies of this kind using a variety of different assay
systems
in mice and they have been recently reviewed (Hirst,
press).
An examination of the available data shows that
can conveniently divide the studies into those involving
anaemia (defined for the purpose of this discussion as
being
induced in 1 day or less) and chronic anaemia induced
days
or more). In every case, acute anaemia caused a
radioresistance in seven different tumour lines, mostly
The picture is less clear when we consider the effect
anaemia. Of the five studies in this category (two
reported here) one (McCormack et al., 1990)
radiosensitivity to be significantly reduced, one (pre-
SCCVII/St study) showed no change in radiosensitivity
the other three showed either modestly (present study)
markedly (Rojas et al., 1987; Walker et al., in press)
radiosensitivity. The radioresistance seen by
McCormack al. (1990) may in some way be related to the
very anaemia (Hct.
- 9%) obtained in their study, but
we must then offer a more detailed explanation. Why should
moderate, chronic anaemia in the mouse produce a more
radiosensitive tumour whereas severe, chronic anaemia
produces the opposite effect? It is helpful to consider the
consequences of a reduction in haematocrit on the oxygen
transport characteristics of the blood. With a decrease in
haematocrit, the haemoglobin content of the blood and
hence its oxygen carrying capacity falls linearly (though not
necessarily to the same extent; see Figure 1); blood viscosity
in tissue also falls, though in a non-linear manner, the
greatest benefit from the point of view of tumour perfusion
occurring for relatively modest drops in haematocrit (Sevick
& Jain, 1989). More extreme reductions produce only a small
further fall in viscosity. We may conclude that over the
haematocrit range from 50 down to 30% the reduction in
viscosity more than makes up for the drop in oxygen carry-
ing capacity while further drops do not adequately compen-
sate and tissue oxygenation suffers. There is, however, no
radiobiological evidence from animal studies to suggest that
acute, moderate anaemia increases radiosensitivity, though
tumour blood flow and oxygen availability have both been
shown to increase after haemodilution in one physiological
study (Jung et al., 1984). Also, why should a change in
radiosensitivity persist at all during chronic anaemia when
adaptive mechanisms should have ample time to restore the
equilibrium (Hirst, 1986)? Consider the situation in which
tumour oxygenation is, on balance, improved by a fall in
haematocrit and viscosity. One consequence of this may be
an improved ability of the less viscous blood to pass through
partially occluded vessels leading to a reduction in the
number of vessels through which blood flow transiently
ceases (the mechanism of acute or perfusion limited hypoxia)
so, although the tumour will appear more radiosensitive
there will be little adaptation to altered oxygenation of such
short duration.
The data of McCormack et al. (1990) showed that at least
in one tumour, very severe chronic anaemia resulted in
radioresistance. If this very low haematocrit does reduce
tissue oxygenation as previously proposed we might expect
that each blood vessel will be capable of supporting fewer
tumour cells, leading to narrower cords of viable cells. We
have previously speculated that this is a major mechanism of
adaptation to lower oxygen delivery (Hirst, 1986) and ac-
counts in part for the lack of residual radioresistance in
tumour of chronically anaemic mice. We should note, how-
ever, that in narrower cords the geometry is altered such that
the layer of cells most distant from the central blood vessel
constitutes a larger fraction of the total tumour cell popula-
tion and the steady state hypoxic fraction should be higher.
This effect may only become apparent for the most severe
anaemia. We do know that cord radii are smaller in tumours
in animals that have been breathing air with reduced P02
(Tannock, 1970; Hirst et al. unpub.) though there is no
evidence for this effect in anaemia.
An alternative explanation for these effects could involve
alterations in the haemoglobin/oxygen binding affinity in res-
ponse to reduced tissue oxygenation. We have previously
speculated (Hirst, 1986; Hirst & Wood, 1987) that this
mechanism could be an important physiological adaptation
leading to the loss of radioresistance after acute induction of
anaemia and there is also ample evidence to show that an
increase in 2,3-diphosphoglycerate and a decrease in binding
affinity follow exposure to lower than normal inspired P02
levels (Siemann et al., 1979; Siemann et al., 1989; Hirst &
Wood, 1987). Furthermore, McCormack et al. (1990) have
shown that binding affinity was reduced (Ps, increased by
21%) in chronically anaemic mice and they proposed that,
provided the anaemia was not too severe, reduced binding
affinity and increased blood flow would compensate for a
reduced oxygen carrying capacity. This mechanism is consis-
tent with the results reported here.
The human data are also difficult to fit to a model in that
they show that many tumours in slightly anaemic patients are
more radioresistant than in patients with higher haemoglobin
levels. An explanation for this could be that human tumour
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cells are better able to utilise anaerobic glycolysis or that
their energy demands are lower and so remain viable after a
period of hypoxia sufficient to kill mouse tumour cells. Thus,
radioresistant hypoxic tumour cells in anaemic patients could
survive to be a clinical problem whereas those in rapidly
growing mouse tumours would die. There is little direct
evidence for these mechanisms though we are forced by what
are now rather convincing data to propose a hypothesis.
However, these arguments make the assumption that the
influence of anaemia on tumour response results from oxygen
deprivation. It has been argued (Dische et al., 1983) that the
relationship may in fact be reversed, with the more aggres-
sive, intrinsically less curable tumours leading to anaemia in
the patient. This possibility has not been disproved.
There is a pressing need to clarify why tumours in anaemic
patients can be more difficult to control with radiotherapy. It
is only by understanding the underlying physiology that we
can hope to offer significantly improved treatment for this
group and perhaps for other patients whose treatment is
compromised by hypoxia.
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